Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show the latest 50

REDUCEDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
−6,081 sh · $167.7K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+8,038 sh · $68.0K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
+11,881 sh · $144.2K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+9,377 sh · $37.4K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
−8,094 sh · $222.7K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
−18,698 sh · $534.9K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
−11,881 sh · $334.2K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
+11,881 sh · $144.2K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
−6,699 sh · $193.1K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
−5,800 sh · $165.6K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+9,377 sh · $76.1K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
−5,182 sh · $153.7K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Rubinstein Julie
Adaptive Biotechnologies Corp · NASDAQ
+11,881 sh · $144.2K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+15,629 sh · $62.4K
Filed 18 Sept 2026SEC Form 4view source
ACQUIREDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+53,091 sh · $644.5K
Filed 18 Sept 2026SEC Form 4view source
ACQUIREDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+13,398 sh · $113.3K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
−107,537 sh · $3.0M
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
−7,869 sh · $224.8K
Filed 18 Sept 2026SEC Form 4view source
ACQUIREDT+30
Lo Francis
Adaptive Biotechnologies Corp · NASDAQ
+23,442 sh · $190.3K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Bobulsky Susan
Adaptive Biotechnologies Corp · NASDAQ
−1,195 sh · $32.3K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDStale
Owen Katey Einterz
Adaptive Biotechnologies Corp · NASDAQ
−12,539 sh
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Owen Katey Einterz
Adaptive Biotechnologies Corp · NASDAQ
−9,615 sh · $250.0K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Hershberg Robert
Adaptive Biotechnologies Corp · NASDAQ
−15,000 sh · $365.9K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Hershberg Robert
Adaptive Biotechnologies Corp · NASDAQ
−15,664 sh · $382.4K
Filed 20 Aug 2026SEC Form 4view source
ACQUIREDStale
Hershberg Robert
Adaptive Biotechnologies Corp · NASDAQ
+15,000 sh · $94.8K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDStale
Neupert Peter M
Adaptive Biotechnologies Corp · NASDAQ
−15,000 sh · $378.4K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
−204 sh · $5.1K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
+321,324 sh · $2.1M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
−318,799 sh · $8.0M
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
+278,676 sh · $1.8M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
−2,525 sh · $64.6K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Neupert Peter M
Adaptive Biotechnologies Corp · NASDAQ
+15,000 sh · $94.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Robins Chad M
Adaptive Biotechnologies Corp · NASDAQ
−278,472 sh · $6.8M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Neupert Peter M
Adaptive Biotechnologies Corp · NASDAQ
−40,000 sh · $1.0M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Neupert Peter M
Adaptive Biotechnologies Corp · NASDAQ
−69,690 sh · $1.8M
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Polen Capital Management
Adaptive Biotechnologies Corp · NASDAQ
102,457 sh · $2.2M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
ARK Investment Management
Adaptive Biotechnologies Corp · NASDAQ
2,090,306 sh · $44.8M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Viking Global Investors
Adaptive Biotechnologies Corp · NASDAQ
29,993,708 sh · $643.4M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Adaptive Biotechnologies Corp · NASDAQ
2,092,969 sh · $29.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Adaptive Biotechnologies Corp · NASDAQ
29,993,708 sh · $416.3M
Filed 31 Mar 2026SEC 13Fview source